Orient Europharma Co Ltd Capital Reinvestment Ratio
Orient Europharma Co Ltd capital reinvestment ratio. Orient Europharma Co Ltd (4120) has a Capital Reinvestment Ratio of 2.68x as of June 2025, meaning it reinvests 3% of its operating cash flow (NT$33.25 Million) in capital expenditures (NT$89.03 Million). Check Orient Europharma Co Ltd total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Orient Europharma Co Ltd (2015–2023)
Capital reinvestment ratio of Orient Europharma Co Ltd from 2015 to 2023. This chart tracks Orient Europharma Co Ltd's Capital Reinvestment Ratio across 8 annual periods. Also explore Orient Europharma Co Ltd annual equity growth to track the company's year-over-year net asset growth rate.
Orient Europharma Co Ltd Capital Reinvestment Ratio by Year (2015–2023)
Orient Europharma Co Ltd capital reinvestment ratio by year from 2015 to 2023. For the full cash flow conversion analysis, see cash efficiency ratio of Orient Europharma Co Ltd.
| Year | Reinvestment Ratio | Operating CF (TWD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 1.56x | NT$64.67 Million | NT$100.70 Million | ▼ -92.3% |
| 2021 | 20.13x | NT$77.65 Million | NT$1.56 Billion | ▲ +5161.6% |
| 2020 | 0.38x | NT$608.55 Million | NT$232.78 Million | ▼ -30.4% |
| 2019 | 0.55x | NT$227.37 Million | NT$124.98 Million | ▼ -36.9% |
| 2018 | 0.87x | NT$231.31 Million | NT$201.61 Million | ▲ +42.5% |
| 2017 | 0.61x | NT$601.08 Million | NT$367.66 Million | ▼ -69.7% |
| 2016 | 2.02x | NT$111.24 Million | NT$224.81 Million | ▲ +467.0% |
| 2015 | 0.36x | NT$643.97 Million | NT$229.54 Million | — |